HemaCare Corp. reported consolidated earnings results for the six months and year ended December 31, 2012. For the six months, the company reported revenue of $9,164,000 against $8,099,000 a year ago. Loss before taxes and discontinued operations was $211,000 against $1,240,000 a year ago. Net loss before discontinued operations was $214,000 against $1,240,000 a year ago. Net loss was $214,000 against $163,000 a year ago. For the six month period, revenue rose by 13%, while the loss from continuing operations decreased by 83% to $214,000 when compared to the year-earlier period. For the year, the company reported revenue of $17,911,000 against $16,245,000 a year ago. Loss before taxes and discontinued operations was $735,000 against $2,157,000 a year ago. Net loss before discontinued operations was $758,000 against $2,167,000 a year ago. Net income was $1,163,000 against net loss of $805,000 a year ago. For the year ended December 31, 2012, revenue rose by 10%, while the loss from continuing operations decreased by 65% to $758,000 compared to the year-earlier period.

HemaCare Corp. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2012. For the quarter, the company's revenue was $4,266,000 compared to $4,238,000 a year ago. Loss before taxes and discontinued operations was $319,000 compared to $432,000 a year ago. Net loss before discontinued operations was $329,000 compared to $432,000 a year ago. Net loss was $329,000 or $0.03 per basic and diluted share compared to $252,000 or $0.03 per basic and diluted share a year ago. For the six months, the company's revenue was $8,747,000 compared to $8,146,000 a year ago. Loss before taxes and discontinued operations was $524,000 compared to $917,000 a year ago. Net loss before discontinued operations was $544,000 compared to $927,000 a year ago. Net income was $1,376,000 or $0.13 per basic and diluted share compared to net loss of $642,000 or $0.07 per basic and diluted share a year ago.

HemaCare Corp. reported unaudited consolidated earnings results for the first quarter ended March 31, 2012. For the quarter, the company’s revenue from continuing operations increased by 15%, from $3.91 million to $4.48 million. On a quarterly sequential basis, consolidated revenue from continuing operations increased by 8.4% and the net operating loss from continuing operations decreased by 68% compared to the quarter ended December 31, 2011. Loss before taxes and discontinued operations was $203,000 against $485,000 a year ago. Net income was $1,707,000 or $0.16 per diluted share against net loss of $390,000 or $0.04 per diluted share a year ago. Loss from continuing operations, net of tax was $213,000 or $0.02 per diluted share against net loss of $495,000 or $0.05 per diluted share a year ago. Net cash provided by operating activities was $260,000 against $448,000 a year ago. Purchases of plant and equipment were $44,000 against $11,000 a year ago.